FDA allows 3-year shelf life for CSL Behring's Privigen

04/22/2010 | Medscape (free registration)

The FDA approved a one-year extension for the shelf life of CSL Behring's 10% liquid intravenous immunoglobulin injection, or Privigen. The change allows the product to be stored at room temperature for three years. The approval was based on a study showing that the immunoglobulin G fraction's purity remains high when the intravenous immunoglobulin product is stored in a controlled environment.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ